{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-089940","form_type":"8-K","ticker":null,"cik":"0001029142","company_name":"DYNAVAX TECHNOLOGIES CORP","filed_at":"2024-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.934990+00:00","generated_at":"2026-05-31T13:20:59.192233+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Dynavax reappoints Kelly MacDonald as CFO upon return from maternity leave","bullets":["Effective August 1, 2024, Board reappointed Kelly MacDonald as CFO (principal financial officer) after maternity leave.","CEO Ryan Spencer had served as Interim CFO during MacDonald's leave; he now returns solely to CEO role.","No change in MacDonald's compensation as a result of the reappointment.","MacDonald's biographical information is referenced from the April 11, 2024 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-089940","json":"https://secwatch.observer/filing/0000950170-24-089940.json","markdown":"https://secwatch.observer/filing/0000950170-24-089940.md","text":"https://secwatch.observer/filing/0000950170-24-089940.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024089940/0000950170-24-089940-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024089940/dvax-20240801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:20:59.192233+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"02ebe85c5a","claim":"Ryan Spencer changed role as Interim Chief Financial Officer at DYNAVAX TECHNOLOGIES CORP.","evidence_excerpt":"Upon Ms. MacDonald's return, Mr. Spencer will no longer serve as Interim CFO but continues as CEO.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024089940/0000950170-24-089940-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving as Interim CFO"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"c6f43f4b7e","claim":"Kelly MacDonald was appointed as Chief Financial Officer at DYNAVAX TECHNOLOGIES CORP.","evidence_excerpt":"Effective August 1, 2024, the Board of Directors of Dynavax Technologies Corporation (the “Company”) re-appointed Kelly MacDonald to serve as the Company’s Chief Financial Officer (principal financial officer) upon her return from maternity leave.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024089940/0000950170-24-089940-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"re-appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}